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ABSTRACT
Trigeminal neuropathy of neoplastic origin accounts for a small percentage of trigeminal neuropathies, though the 
prognosis may be very poor. It is important to discard neoplastic processes in patients with numbness of the trigeminal 
territory. We present 7 cases of trigeminal neuropathy secondary to tumors: in four cases there were antecedents of 
systemic neoplastic disease, while in the remaining three cases neuropathy was the first manifestation of the tumor. The 
lesion was located in the mandible in three cases, in the region of the skull base in one patient, and in the brainstem and 
brain in one case each. In one case the lesion level could not be identified. The course was very poor in 5 cases. Reco-
very was only recorded in one patient in whom the symptoms were seen to disappear after acoustic nerve neurinoma 
resection. The lesions underlying neoplastic trigeminal neuropathy can be located at any point along the trajectory of 
the trigeminal nerve, and their prognosis is very poor.
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RESUMEN
Las neuropatías del trigémino de origen tumoral suponen un bajo porcentaje de las neuropatías trigeminales, pero pueden 
tener muy mal pronóstico. Es importante descartar una neoplasia en los pacientes con adormecimiento en el territorio 
del trigémino. Presentamos 7 casos de neuropatías trigeminales secundarias a tumores; en 4 existían antecedentes de 
neoplasias sistémicas previas y en 3 la neuropatía fue el primer signo de la enfermedad tumoral. En tres ocasiones la 
lesión se localizó en mandíbula, una en base de cráneo, una en troncoencéfalo, una a nivel cerebral y en una no se en-
contró el nivel lesional. La evolución  fue muy mala en 5 pacientes; sólo se recuperó un caso en el que tras la resección de 
un neurinoma del acústico desaparecieron los síntomas. Las lesiones que producen neuropatías trigeminales tumorales 
pueden localizarse a lo largo de todo el trayecto trigeminal y las neoplásicas tienen un pronóstico ominoso.
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INTRODUCTION
Trigeminal neuropathies (TNs) manifest as skin and mu-
cosal numbness in the region innervated by the trigeminal 
nerve (1). Their importance is explained by the fact that 
TN may represent the first manifestation of tumor disease, 
or of relapse in patients with prior neoplastic processes. 
As such, these manifestations are ominous, and patient life 
expectancy is often short (2). TN frequently reflects metas-
tatic invasion or contiguity spread of the tumor lesion to 
the cranial nerves (3). TNs have been reported secondary 
to the following processes: tumors located in the region of 
the pontocerebellar angle (4), Gasser’s ganglion, the trige-
minal roots (5), or nasopharynx and maxillary sinus (6); and 
mandibular benign (7) or malignant lesions (8-10).
The degree of involvement and the location of the lesion are 
highly variable. Despite availability of the most recent early 
diagnostic techniques, it is difficult to differentiate “benign” 
TN from “malignant” tumor-associated presentations. Early 
clinical and radiological evaluation is of crucial importance 
(11). In the event of sensory defects in the territory of the 
trigeminal nerve, the presence of a primary tumor or of 
metastatic relapse of malignant disease at some point along 
the trigeminal trajectory must be discarded (12).
The present study describes 7 patients with neoplastic tri-
geminal neuropathies. An evaluation is made of the clinical 
manifestations, the location and etiological diagnosis of the 
lesions, and patient evolution.
MATERIAL AND METHOD
The study includes the cases of  neoplastic trigeminal 
neuropathies seen in the Dental Clinic of the School of 
Medicine and Dentistry (Valencia University, Spain) in the 
period between 1988 and 2002. The relevant patient data 
and antecedents were recorded. The diagnosis of TN was 
based on the clinical manifestations. All patients reported 
orofacial numbness in the territory of one or more branches 
of the trigeminal nerve, and clinical examination revealed 
sensory defects of one or more branches of this nerve (12). 
The presence or absence of pain associated to the sensory 
defect was documented, along with the type of pain and its 
response to pharmacological treatment.
Clinical exploration was made of the oral cavity and cranial 
nerves. An extraoral panoramic X-ray study was made in 
all cases, together with maxillofacial or brain computed 
tomography (CT) and/or brain magnetic resonance imaging 
(MRI). In patients with mandibular lesions, the latter were 
subjected to biopsy, while patients with central nervous 
system disorders underwent biopsy or surgery, depending 
on the process involved. The treatment provided and the 
course of the disease were documented. 
RESULTS
Seven patients were studied. The mean age was 47 years 
(range 35-72 years). There were four males and three females 
(Table 1). As to the personal antecedents, two patients had 
a history of breast tumors (cases 1 and 4), one had prostate 
cancer (case 3), and one presented lip carcinoma (case 3). 
Three patients referred pain of a neurogenic nature (cases 1, 
2 and 5), located in the trigeminal territory affected by the 
neuropathy. Pain intensity was great in all cases, with good 
initial response to pharmacological treatment in the form 
of carbamazepine and amitriptyline. In cases 1 and 2 the 
pain was atypical, continuous and with added crises. As the 
disease process evolved, the pain worsened, and the medica-
tion became less effective. In the patient with acoustic nerve 
neurinoma the pain exhibited typical features (fulgurating 
and characterized by crises lasting seconds), and improved 
with carbamazepine. The pain disappeared after surgical 
treatment of the tumor.
As to the location of the sensory defect, four patients showed 
involvement of the territory of the mental nerve, while one 
patient presented combined involvement of the second and 
third trigeminal branches. One subject showed involvement 
of all three branches. In one patient the sensory defect was 
located on the left side (case 5), while in 6 cases it was con-
fined to the right side of the face.
The intraoral exploration only detected anomalies in case 2, 
in the form of a mass in the mandibular retromolar trigone. 
The clinical examination revealed no alterations in trigemi-
nal motor function. As regards the rest of the cranial nerves, 
case 5 presented left hypoacusia, while the rest of patients 
showed no alterations.
Orthopantomography and maxillofacial CT identified 
mandibular osteolytic lesions in three patients: squamous 
cell carcinoma of the mandibular angle was recorded in case 
2, corresponding to a patient who had undergone surgery 
for lower lip squamous cell carcinoma three years before. 
The remaining three cases corresponded to mandibular 
metastatic lesions secondary to breast cancer  (case 4)(Fig. 
1, A, B and C) and lung cancer (case 7). 
In three cases brain CT or MRI revealed alterations. In 
this context, case 5 presented an acoustic nerve neurinoma 
within the pontocerebellar angle, while case 1 corresponded 
to a metastatic lesion that destroyed the tip of the petrosal 
bone in a patient with a history of breast cancer (Fig. 2 A 
and B). Lastly, case 6 corresponded to a brain tumor initially 
manifesting as facial numbness – the final diagnosis being 
glioblastoma multiforme (Fig. 3. A and B). 
In case 3 we observed no orthopantomographic or brain or 
maxillary CT alterations. This patient had been diagnosed 
with prostate cancer.
In cases 1, 4 and 7 (Table 2), TN was caused by distant 
metastases of  systemic cancers. Case 2 corresponded to 
local spread of a lower lip carcinoma – possibly via the 
perineural route. In all four patients TN was the first sign 
of relapse of the malignancy. In case 3 neuropathy of the 
chin region manifested in a patient with a previous prostate 
neoplasm, though metastasis could not be demonstrated. 
In cases 5 and 6, facial numbness was the first sign of the 
disease (corresponding to acoustic nerve neurinoma and 
glioblastoma multiforme, respectively), while in case 7 TN 
was the first sign of metastatic spread of an occult tumor 
subsequently identified as lung adenocarcinoma. 
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Case Lesion diagnosis Lesion level 
Time to diagnosis 
of trigeminal 
neuropathy 
Treatment Course duration of follow-up






improvement Control 8 months 
2
Metastasis of squamous cell 
carcinoma in mandibular 
angle





Worsening Death in 8 months 
3
Systemic metastasis of 
prostate carcinoma. 
Paraneoplastic? 
Not known 3 years Chemotherapy No improvement Death in 30 months 
4 Mandibular metastasis of breast carcinoma Mandible 10 months Chemotherapy No improvement Death in 10 months 






Control 12 months 
6 Glioblastoma multiforme of the brain Brain 6 months Chemotherapy Worsening Death in 6 months 
7 Mandibular metastasis of lung adenocarcinoma Mandible 8 months Chemotherapy Worsening Death in 12 months 
Table 1. Neoplastic trigeminal neuropathy; patient data. (F: female, M: male, CT: computed tomography, MRI: magnetic resonance imaging).
Table 2. Diagnosis and course of patients with neoplastic trigeminal neuropathy.
Age, 
years Sex Personal history Symptoms 
Location of 
neuropathy Orthopantomography Mandibular CT 
Brain CT / 
MRI 
48 F Breast cancer 6 years before Pain and numbness 1, 2 and 3 No alteration No alteration Infiltration petrosal tip 





72 M Prostate cancer 4 years before Numbness 3 (mental n.) No alteration No alteration No alteration 






48 F No Pain and numbness 1, 2 and 3 No alteration - Pontocerebellar angle tumor 
35 M No Numbness 2 and 3 No alteration No alteration Brain tumor 
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Fig. 1. (Case 4). A. Area of patient numbness. B. Extraoral panoramic X-
ray view showing osteolytic lesions in the region of the mandibular angle. 




Fig. 2. A Fig. 2. B
Fig. 2. (Case 1). A. Area of patient numbness. B. Brain computed tomographic view showing destruction of the tip of the petrosal bone.
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Regarding treatment, in the cases of pain the patients re-
ceived carbamazepine and/or amitriptyline, together with 
specific management for the associated neoplastic process. 
The patients with antecedents of systemic malignancy were 
subjected to chemotherapy, both in the case of radiological 
manifestations of metastatic lesions (in the base of the skull 
(case 1) or mandible (cases 4 and 7), and in those patients 
without evidence of metastasis (case 3). One patient (case 6) 
with cerebral glioblastoma multiforme received chemothera-
py, in the same way as another patient (case 2) with perineural 
metastatic spread of lip cancer affecting the lower jaw. Case 
5 (acoustic nerve neurinoma) underwent surgery. 
Regarding the course of the disease, the patients showed 
slow progression from the onset of symptoms to the diag-
nosis of TN: from 6 months in case 1, to three years in case 
3. In the latter patient TN coincided with the diagnosis of 
systemic tumor spread. In case 6 the clinical manifestations 
corresponded to TN of the second and third branch and 
remained stationary during 6 months. There was no associa-
ted pain or involvement of other cranial nerves suggesting 
the existence of a lesion in the sensory roots of the nerve, 
in Gasser’s ganglion, or in the corresponding branches. 
However, brain MRI demonstrated the presence of a space-
occupying cortical lesion. Posteriorly, the patient developed 
sensory alterations of the contralateral upper limb and other 
clinical manifestations.
Regarding the duration of  follow-up, four patients died 
within the first year (cases 2, 4, 6 and 7), while case 3 died 
after 13 months. Case 1 failed to improve of the neuropathy 
during the 8-month follow-up period (this patient was sub-
sequently lost to follow-up), and only case 5 showed clinical 
recovery (acoustic nerve neurinoma). 
DISCUSSION
The importance of the diagnosis of neoplastic trigeminal 
neuropathy is that the disorder may manifest in the context 
of a systemic neoplastic process, and in some cases can pre-
cede the diagnosis of the malignancy (9,13). In this context, 
in the review by Massey et al. (14), 47% of the patients 
reported dysesthesias prior to diagnosis of the cancer. This 
fact makes it necessary to explore the presence of a possible 
occult neoplasm in non-oncological patients diagnosed with 
mental nerve neuropathy – focusing special attention on 
bronchopulmonary and breast malignancies and lympho-
proliferative processes, which represent the most common 
underlying etiologies. Vadell et al. (12) presented 5 patients 
in the context of progressing disease. TN manifested in two 
of our patients with antecedents of breast adenocarcinoma, 
in one patient with prostate cancer, and in another individual 
with lip carcinoma. In all of these cases numbness of the 
trigeminal territory was the first sign of neoplastic relapse. 
In the remaining three cases, TN was the first manifestation 
of the disease: two primary tumors (one benign and the 
other malignant), and a case of tumor metastasis. 
Clinically, neoplastic trigeminal neuropathies can manifest 
as numbness or numbness with pain, in an association 
of  deficiency and irritative symptoms (15,16). Malignant 
mental neuropathy is characterized by spontaneous, non-
traumatic anesthesia of the region innervated by the mental 
nerve. The sensory defect includes the skin and mucosa of 
the lower lip (14). All of our patients showed involvement 
of the mental nerve, either alone or in combination with one 
or both of the remaining trigeminal nerve branches. Tumors 
affecting the trigeminal nerve may cause atypical neuralgia 
Fig. 3. A
Fig. 3. B
Fig. 3. (Case 7) A. Facial view showing the area of numbness. B. Brain magnetic resonance imaging view showing a lesion compatible with glioblastoma 
multiforme.
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with sensory loss – the associated pain being intense, with 
progressive neurological impairment (17). In our series there 
was associated neurogenic pain in three cases. The pain was 
described as fulgurating and lasted seconds in one patient, 
while in the rest the pain exhibited atypical characteristics. 
Calvin et al. (18) suggested that such pain may be caused by 
tumor compression of the sensory roots of the trigeminal 
nerve, resulting in areas of demyelization. 
Different authors have stressed the importance of  per-
forming a complete radiological study of  patients with 
trigeminal neuropathy, in order to discard the possible 
existence of a lesion in the brain, brainstem, preganglionic 
region, in Gasser’s ganglion or in the cavernous sinus, or 
in the extracranial zone of the three trigeminal branches 
– with exploration of the entire trajectory of the fifth cra-
nial nerve (12,19-22). In TN it is necessary in all cases to 
discard a possible tumor lesion - benign (7,8) or malignant 
(12) – at any point along the trajectory of the trigeminal 
nerve, and the lesion cannot be located based on the clinical 
signs and symptoms alone. Three of our patients presented 
mandibular carcinomas. In the patient with prostate cancer 
we detected no radiographic lesions; this case may have co-
rresponded to a paraneoplastic lesion, as has been suggested 
by some investigators (14). The patient with a neurinoma 
in the pontocerebellar angle presented atypical neurogenic 
pain together with TN and hypoacusia. Another patient 
had a brain lesion initially manifesting as contralateral 
facial numbness.
Regarding treatment, and once the background disease 
causing the neuropathy had been diagnosed, our patients 
were referred to the required specialists for systemic therapy. 
In the case of operable malignant or benign tumors, surgery 
is indicated – as in our patient with an acoustic nerve neu-
rinoma. Carbamazepine and amitriptyline were prescribed 
in the cases presenting neurogenic pain, with initial partial 
symptoms improvement. 
The appearance of TN of malignant origin is classically 
associated with a poor prognosis involving a short patient 
life expectancy, and is regarded as an ominous sign of the 
disease (23). Laurencet et al. (2) reported a mean survival 
after the diagnosis of malignant TN of less than one year. 
In our series, 5 patients had a very poor prognosis, with 
short survival: most died within one year of follow-up. Of 
note is the fact that a considerable period of time elapsed 
from the onset of facial numbness to the diagnosis of TN. 
This may have been because the patients did not consider 
the symptoms to be particularly important, and did not seek 
medical help. Only one of our patients showed complete 
recovery. This case corresponded to a neurinoma of the 
acoustic nerve, and all the clinical manifestations disappea-
red after surgical removal of the tumor. 
If  a patient with a tumor develops trigeminal facial numb-
ness, the condition should be regarded as evidence of tumor 
relapse – with a very poor associated prognosis. In the event 
of facial numbness manifesting in a patient without disease 
antecedents of interest, the location of the lesion should be 
established, with diagnosis of the disorder, and considering 
that the condition may effectively correspond to the first 
manifestation of a neoplastic process. 
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